Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use
The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 recep...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Cid-Nunez, Jose Maria Klein, Brian D Ceusters, Marc Andre Bone, Roger Francis Twyman, Roy E White, H. Steven Van Osselaer, Nancy Eulalie Sylvain Trabanco-Suárez, Andrés Avelino Lavreysen, Hilde Pype, Stefan Maria Christiaan |
description | The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020286269A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020286269A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020286269A13</originalsourceid><addsrcrecordid>eNqNS0sKwjAQ7caFqHcYcC1ohaJLEcUD6FqmddoOJJmQmQgewjubhe7lPXi837R6H8W3HNBYgkInPiZWDgNEUTZ-EqBzokaJO_DyyA5NkoKkQht_DQ4SWK3kPXgybMWSxFIMLht6LKuhuEQdxfIHza29IkENGB5gI3GCrDSvJj06pcVXZ9XyfLoeLyuKcieN2FEgux9u9bpg19TN_rDZ_rf6ACe7UOI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use</title><source>esp@cenet</source><creator>Cid-Nunez, Jose Maria ; Klein, Brian D ; Ceusters, Marc Andre ; Bone, Roger Francis ; Twyman, Roy E ; White, H. Steven ; Van Osselaer, Nancy Eulalie Sylvain ; Trabanco-Suárez, Andrés Avelino ; Lavreysen, Hilde ; Pype, Stefan Maria Christiaan</creator><creatorcontrib>Cid-Nunez, Jose Maria ; Klein, Brian D ; Ceusters, Marc Andre ; Bone, Roger Francis ; Twyman, Roy E ; White, H. Steven ; Van Osselaer, Nancy Eulalie Sylvain ; Trabanco-Suárez, Andrés Avelino ; Lavreysen, Hilde ; Pype, Stefan Maria Christiaan</creatorcontrib><description>The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210121&DB=EPODOC&CC=AU&NR=2020286269A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210121&DB=EPODOC&CC=AU&NR=2020286269A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Cid-Nunez, Jose Maria</creatorcontrib><creatorcontrib>Klein, Brian D</creatorcontrib><creatorcontrib>Ceusters, Marc Andre</creatorcontrib><creatorcontrib>Bone, Roger Francis</creatorcontrib><creatorcontrib>Twyman, Roy E</creatorcontrib><creatorcontrib>White, H. Steven</creatorcontrib><creatorcontrib>Van Osselaer, Nancy Eulalie Sylvain</creatorcontrib><creatorcontrib>Trabanco-Suárez, Andrés Avelino</creatorcontrib><creatorcontrib>Lavreysen, Hilde</creatorcontrib><creatorcontrib>Pype, Stefan Maria Christiaan</creatorcontrib><title>Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use</title><description>The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNS0sKwjAQ7caFqHcYcC1ohaJLEcUD6FqmddoOJJmQmQgewjubhe7lPXi837R6H8W3HNBYgkInPiZWDgNEUTZ-EqBzokaJO_DyyA5NkoKkQht_DQ4SWK3kPXgybMWSxFIMLht6LKuhuEQdxfIHza29IkENGB5gI3GCrDSvJj06pcVXZ9XyfLoeLyuKcieN2FEgux9u9bpg19TN_rDZ_rf6ACe7UOI</recordid><startdate>20210121</startdate><enddate>20210121</enddate><creator>Cid-Nunez, Jose Maria</creator><creator>Klein, Brian D</creator><creator>Ceusters, Marc Andre</creator><creator>Bone, Roger Francis</creator><creator>Twyman, Roy E</creator><creator>White, H. Steven</creator><creator>Van Osselaer, Nancy Eulalie Sylvain</creator><creator>Trabanco-Suárez, Andrés Avelino</creator><creator>Lavreysen, Hilde</creator><creator>Pype, Stefan Maria Christiaan</creator><scope>EVB</scope></search><sort><creationdate>20210121</creationdate><title>Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use</title><author>Cid-Nunez, Jose Maria ; Klein, Brian D ; Ceusters, Marc Andre ; Bone, Roger Francis ; Twyman, Roy E ; White, H. Steven ; Van Osselaer, Nancy Eulalie Sylvain ; Trabanco-Suárez, Andrés Avelino ; Lavreysen, Hilde ; Pype, Stefan Maria Christiaan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020286269A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Cid-Nunez, Jose Maria</creatorcontrib><creatorcontrib>Klein, Brian D</creatorcontrib><creatorcontrib>Ceusters, Marc Andre</creatorcontrib><creatorcontrib>Bone, Roger Francis</creatorcontrib><creatorcontrib>Twyman, Roy E</creatorcontrib><creatorcontrib>White, H. Steven</creatorcontrib><creatorcontrib>Van Osselaer, Nancy Eulalie Sylvain</creatorcontrib><creatorcontrib>Trabanco-Suárez, Andrés Avelino</creatorcontrib><creatorcontrib>Lavreysen, Hilde</creatorcontrib><creatorcontrib>Pype, Stefan Maria Christiaan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Cid-Nunez, Jose Maria</au><au>Klein, Brian D</au><au>Ceusters, Marc Andre</au><au>Bone, Roger Francis</au><au>Twyman, Roy E</au><au>White, H. Steven</au><au>Van Osselaer, Nancy Eulalie Sylvain</au><au>Trabanco-Suárez, Andrés Avelino</au><au>Lavreysen, Hilde</au><au>Pype, Stefan Maria Christiaan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use</title><date>2021-01-21</date><risdate>2021</risdate><abstract>The present invention relates to combinations comprising a positive allosteric modulator ("PAM") of metabotropic glutamatergic receptor subtype 2 ("mGluR2") or a pharmaceutically acceptable salt or a solvate thereof, or an orthosteric agonist of metabotropic glutamatergic 5 receptor subtype 2 compound or a pharmaceutically acceptable salt or a solvate thereof, and a synaptic vesicle protein 2A ("SV2A") ligand.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2020286269A1 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T21%3A34%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Cid-Nunez,%20Jose%20Maria&rft.date=2021-01-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020286269A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |